Stedical Tops MedTech Outlook's Global Top 10 Wound Management Solutions Providers List

MedTech Outlookis an internationally authoritative professional media outlet in the medical technology industry, annually selecting niche sectors from around the worldTop 10Top Provider of Solutions.

The purpose of this list is to help decision-makers better navigate the multitude of products on the market, integrating advanced concepts, industry trends, challenges, and highly impactful innovative medical technologies.。

Saidikang is a medical technology company with globally leading platform technologies in the fields of tissue engineering and regenerative medicine, having established R&D centers and production bases in both China and the United States. ItsPermeaDerm: The First Tissue-Engineered Skin Product® is the first adaptive biosynthetic skin scaffold system introduced in the field of wound management.Approved by the U.S. FDA and launched for sale in the U.S. market.In addition to its applications in skin substitution and wound repair, the platform technology underlying PermeaDerm® tissue-engineered skin can be further extended to fields such as general surgery, orthopedic trauma, neurology, and cardiovascular medicine.

The first post-marketing clinical study of CytoMedix PermeaDerm® globally has recently been launched, with plans to enroll 68 subjects across 12 authoritative clinical centers in the United States. Professor David Greenhalgh, Chief of Burn Surgery at Shriners Hospitals for Children Northern California—the largest pediatric burn center in the U.S.—and President-Elect of the International Society for Burn Injuries, serves as the Principal Investigator (PI).

The company is set to simultaneously launch domestic clinical trials in China, with Academician Xia Zhaofan, an academician of the Chinese Academy of Engineering and Director of the Burn and Trauma Center at Changhai Hospital affiliated with Naval Medical University, serving as the Principal Investigator (PI).

Saidikang is not only a pioneer in technological innovation in the field of wound repair, but also addresses the urgent need for upgraded clinical treatments for a large number of patients with acute and chronic wounds worldwide through disruptive innovations in tissue engineering and regenerative medicine technologies.